Commitments and Contingencies (Tables)
|
6 Months Ended |
Mar. 31, 2026 |
|---|
| Commitments and Contingencies Disclosure [Abstract] |
|
| Schedule of operating lease costs |
| Schedule of operating lease costs | |
| |
| |
| |
|
| | |
Three months ended March 31, | |
Six months ended March 31, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Operating lease costs | |
$ | 33 | | |
$ | 33 | | |
$ | 69 | | |
$ | 66 | |
|
| Defined Contribution Plan Disclosures [Table Text Block] |
| | |
| |
| |
| |
|
| | |
Three Months Ended March 31, | |
Six Months ended March 31, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| Contributions to 401(k) plan | |
$ | 57 | | |
$ | 67 | | |
$ | 82 | | |
$ | 115 | |
|
| Schedule of stock option activity |
| Schedule of stock option activity | | |
| | | |
| | | |
| | | |
| | |
| | |
Number of Options | |
Weighted Average Exercise Price
($) | |
Weighted Average Grant Date Fair Value
($) | |
Aggregate intrinsic value
($) |
| Outstanding, September 30, 2025 | | |
| 14,961,583 | | |
| 7.25 | | |
| 5.46 | | |
| 39,715,608 | |
| Granted | | |
| 167,000 | | |
| 4.08 | | |
| 3.10 | | |
| — | |
| Exercised | | |
| (2,084 | ) | |
| 3.17 | | |
| 2.40 | | |
| 2,772 | |
| Expired | | |
| (125,000 | ) | |
| 11.14 | | |
| 5.35 | | |
| — | |
| Forfeited | | |
| (641,249 | ) | |
| 14.48 | | |
| 3.17 | | |
| — | |
| Outstanding, March 31, 2026 | | |
| 14,360,250 | | |
| 6.86 | | |
| 5.18 | | |
| 836,386 | |
| Exercisable, March 31, 2026 | | |
| 10,750,671 | | |
| 5.81 | | |
| 4.52 | | |
| 836,386 | |
|
| Schedule of summarizes information about stock options |
| | Schedule of summarizes information about stock options | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| | |
| |
Number of | |
Weighted average | |
Weighted | |
Number of | |
Weighted |
| Range of exercises prices | |
outstanding | |
remaining contractual | |
average | |
vested | |
average |
| From | |
To | |
options | |
life (in years) | |
exercise price | |
options | |
exercise price (vested options) |
| $ | 2.30 | | |
$ | 5.00 | | |
| 4,480,616 | | |
| 2.91 | | |
$ | 3.06 | | |
| 4,270,615 | | |
$ | 3.00 | |
| $ | 5.01 | | |
$ | 7.00 | | |
| 3,241,203 | | |
| 4.67 | | |
$ | 5.61 | | |
| 2,647,539 | | |
$ | 5.67 | |
| $ | 7.01 | | |
$ | 9.00 | | |
| 4,169,431 | | |
| 6.10 | | |
$ | 8.08 | | |
| 2,612,517 | | |
$ | 7.93 | |
| $ | 9.01 | | |
$ | 13.00 | | |
| 1,469,000 | | |
| 6.23 | | |
$ | 10.20 | | |
| 1,015,000 | | |
$ | 10.24 | |
| $ | 13.01 | | |
$ | 25.00 | | |
| 1,000,000 | | |
| 5.33 | | |
$ | 17.96 | | |
| 205,000 | | |
$ | 17.39 | |
| | | | |
| | | |
| 14,360,250 | | |
| 4.74 | | |
$ | 6.86 | | |
| 10,750,671 | | |
$ | 5.81 | |
|
| Schedule of general and administrative expenses and research and development expenses |
| Schedule of general and administrative expenses and research and development expenses | |
| | | |
| | | |
| | | |
| | |
| | |
Three months ended March 31, | |
Six months ended March 31, |
| | |
2026 | |
2025 | |
2026 | |
2025 |
| General and administrative | |
$ | 507 | | |
$ | 605 | | |
$ | 977 | | |
$ | 1,407 | |
| Research and development (recovery) | |
| (193 | ) | |
| 844 | | |
| 444 | | |
| 2,097 | |
| Total share-based compensation | |
$ | 314 | | |
$ | 1,449 | | |
$ | 1,421 | | |
$ | 3,504 | |
|
| Schedule of weighted average assumptions for fair value of each option award |
| Schedule of weighted average assumptions for fair value of each option award | |
| | | |
| | |
| | |
2026 | |
2025 |
| Risk-free interest rate | |
| 3.68 | % | |
| 3.98 | % |
| Expected life of options (years) | |
| 5.64 | | |
| 5.56 | |
| Annualized volatility | |
| 86.63 | % | |
| 86.49 | % |
| Dividend rate | |
| 0.00 | % | |
| 0.00 | % |
|